PAPER Rao HV, Thirumangalakudi L, Desmond P, Grammas P

Cyclin D1, cdk4, and Bim are involved in thrombin-induced apoptosis in cultured cortical neurons.

J Neurochem. 2007 Apr;101(2):498-505. PubMed: 17254021

PAPER Johanson C, Flaherty S, Messier A, Duncan J, Silverberg G

Expression of the beta-amyloid transporter, LRP-1, in aging choroid plexus: implications for the CSF-brain system in NPH and Alzheimer's disease.

Cerebrospinal Fluid Res. 2006;3 Suppl 1:S29. PubMed: 17254252

PAPER Plassman BL, Steffens DC, Burke JR, Welsh-Bohmer KA, Newman TN, Drosdick D, Helms MJ, Potter GG, Breitner JC

Duke Twins Study of Memory in Aging in the NAS-NRC Twin Registry.

Twin Res Hum Genet. 2006 Dec;9(6):950-7. PubMed: 17254435

PAPER He Y, Wang L, Zang Y, Tian L, Zhang X, Li K, Jiang T

Regional coherence changes in the early stages of Alzheimer's disease: a combined structural and resting-state functional MRI study.

Neuroimage. 2007 Apr 1;35(2):488-500. PubMed: 17254803

PAPER Capellà D, Vidal X

Comparative analysis of mortality in patients with Alzheimer's disease treated with donepezil and galantamine.

Age Ageing. 2007 Mar;36(2):234; author reply 235. PubMed: 17255086

PAPER Murray IV, Liu L, Komatsu H, Uryu K, Xiao G, Lawson JA, Axelsen PH

Membrane-mediated amyloidogenesis and the promotion of oxidative lipid damage by amyloid beta proteins.

J Biol Chem. 2007 Mar 30;282(13):9335-45. PubMed: 17255094

PAPER Yamamoto M, Kiyota T, Horiba M, Buescher JL, Walsh SM, Gendelman HE, Ikezu T

Interferon-gamma and tumor necrosis factor-alpha regulate amyloid-beta plaque deposition and beta-secretase expression in Swedish mutant APP transgenic mice.

Am J Pathol. 2007 Feb;170(2):680-92. PubMed: 17255335

PAPER Utsuki T, Uchimura N, Irikura M, Moriuchi H, Holloway HW, Yu QS, Spangler EL, Mamczarz J, Ingram DK, Irie T, Greig NH

Preclinical investigation of the topical administration of phenserine: transdermal flux, cholinesterase inhibition, and cognitive efficacy.

J Pharmacol Exp Ther. 2007 Apr;321(1):353-61. PubMed: 17255466

PAPER Jockers-Scherübl MC, Hellweg R

Atypical antipsychotic drugs and Alzheimer's disease.

N Engl J Med. 2007 Jan 25;356(4):416-7; author reply 417-8. PubMed: 17256186

PAPER Wiltfang J, Esselmann H, Bibl M, Hüll M, Hampel H, Kessler H, Frölich L, Schröder J, Peters O, Jessen F, Luckhaus C, Perneczky R, Jahn H, Fiszer M, Maler JM, Zimmermann R, Bruckmoser R, Kornhuber J, Lewczuk P

Amyloid beta peptide ratio 42/40 but not A beta 42 correlates with phospho-Tau in patients with low- and high-CSF A beta 40 load.

J Neurochem. 2007 May;101(4):1053-9. PubMed: 17254013

PAPER Shioi J, Georgakopoulos A, Mehta P, Kouchi Z, Litterst CM, Baki L, Robakis NK

FAD mutants unable to increase neurotoxic Abeta 42 suggest that mutation effects on neurodegeneration may be independent of effects on Abeta.

J Neurochem. 2007 May;101(3):674-81. Epub 2007 Jan 24 PubMed: 17254019

FGFR3

ANTIBODY polyclonal manufacturer Cat# NB600-1360 immunogen = Synthetic peptide: A E E E L V E A D E A G S V K corresp. to aa 359-372 of human FGFR3 with a C-terminal, conjugated with glutaraldehyde to KLH liquid antisera, BSA, PBS, azide FGF Receptor 3; no reactio

FGFR2 (3F4)

ANTIBODY monoclonal 3F4 manufacturer Cat# H00002263-M04<br /> available in North America only <br /> supplied by Abnova immunogen = partial recombinant FGFR2 purified, no preservative FGFR2- fibroblast growth factor receptor 2 (bacteria-expressed kinas

FGFR2 (2C11)

ANTIBODY monoclonal 2C11 manufacturer Cat# H00002263-M03<br /> available in North America only <br /> supplied by Abnova immunogen = partial recombinant FGFR2 purified, no preservative FGFR2- fibroblast growth factor receptor 2 (bacteria-expressed kina

FGFR2 (1G3)

ANTIBODY monoclonal 1G3 manufacturer Cat# H00002263-M01<br /> available in North America only <br /> supplied by Abnova immunogen = partial recombinant FGFR2 purified, no preservative FGFR2- fibroblast growth factor receptor 2 (bacteria-expressed kinas